Searchable abstracts of presentations at key conferences in endocrinology

ea0022p318 | Diabetes | ECE2010

Proinflammatory cytokines and serum lipids in patients with diabetes mellitus 2

Tzioras Constantinos , Brionidou Adromaxi , Klonaris Nikos , Bantila Alexandros

Introduction: Recently, several cytokines attracted considerable attention as potential effectors of insulin resistance and endothelium dysfunction, both associated with type 2 diabetes mellitus (T2DM) pathophysiology.Serum lipids disturbances also observed in inflammation and immunologic disorders have been found to largely depend on proinflammatory cytokines release.Aim: To establish the presence of cytokines levels disturbances ...

ea0021p347 | Steroids | SFEBES2009

Regulation of glucocorticoid receptor activity by cellular stress

Davies Laura , Sadeq Malihah , Demonacos Constantinos , Krstic-Demonacos Marija

Cofactors of the nuclear hormone receptors are crucial in regulating their transcriptional activity. The glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily, involved in the regulation of metabolism, inflammation and stress–responses and many GR cofactors are known, including p300. Here, we identify a new cofactor for GR: TTC5/Strap, tetratricopeptide repeat domain 5/ stress–responsive activator of p300. Strap is a TPR motif containin...

ea0020p362 | Diabetes and Cardiovascular | ECE2009

Klotho gene polymorphism may be a genetic risk factor for metabolic syndrome in men

Katsoulis Constantinos , Chatzikyriakidou Anthi , Xita Nektaria , Georgiou Ioannis , Tsatsoulis Agathocles

Introduction: Klotho has an important role in insulin signaling and the development of ageing-like phenotypes in mice. Recently, the G-395A polymorphism in the promoter region of the human klotho gene has been reported to affect promoter function. It has been also shown to be an independent genetic risk factor for atherosclerotic cardiovascular disease. The aim of this study was to examine the possible role of this polymorphism in the metabolic syndrome....

ea0015p55 | Clinical practice/governance and case reports | SFEBES2008

Cushing’s syndrome or is it? a case report

Christodoulides Constantinos , Walker Neil , Vincent Alex , Karavitaki Niki , Wass John

A 62-year-old lady was referred to our Department with a nine-month history of facial swelling, easy bruising, and centripetal weight gain. She had a longstanding history of depression, hypertension, and osteoarthritis. She was taking citalopram, buspirone, atenolol and bendrofluazide. A few months earlier she had received bilateral intra-articular knee injections at her local hospital for arthritic pain. On examination she had thin skin with multiple bruises, facial puffiness...

ea0015p96 | Clinical practice/governance and case reports | SFEBES2008

Abbreviated metyrapone day curves: do they work?

Stoesser Nicole , Christodoulides Constantinos , Karavitaki Niki , Wass John AH

Introduction: Metyrapone is used as holding treatment in patients with Cushing’s syndrome awaiting definitive treatment or as adjunctive treatment following pituitary irradiation. The metyrapone day curve is used to assess the adequacy of suppression of cortisol synthesis, and in our institution involves taking four blood cortisol samples at 9 am, 12 pm, 3 pm and 6 pm respectively. A mean result between 200 and 300 nmol/l is deemed satisfactory.Aims...

ea0013p102 | Clinical practice/governance and case reports | SFEBES2007

Gastric adenocarcinoma and ectopic ACTH syndrome

Christodoulides Constantinos , Walker Neil , Karavitaki Niki , Wass John

Ectopic ACTH syndrome (EAS) is characteristically associated with neuroendocrine tumours and small cell carcinomas (SCC) typically of the bronchus. We report a rare case of EAS secondary to gastric adenocarcinoma.A 52-year old man presented to our department with a few week history of proximal myopathy, easy bruising, anxiety and weight loss. He was tanned and hypertensive. Laboratory investigations revealed hypokalaemia (2.3 mmol/l), hyperglycaemia and ...

ea0081p501 | Thyroid | ECE2022

Thyroid involvement in the context of sars-cov-2 infection

Athanasiou Ifigenia Kostoglou , Athanassiou Lambros , Nikolakopoulou Sofia , Konstantinou Alexandra , Mascha Olga , Bliziotis Ioannis , Samaras Charilaos , Athanassiou Panagiotis

Introduction: The SARS-CoV-2 virus has severely affected humanity. The disease causes pneumonia which may be severe. In many cases, patients, especially if there are comorbidities, may have a fatal outcome. The disease affects all organs and the variability of its manifestations has attracted intense scientific interest. Aim: The aim of the study was to describe the case of a patient who developed subacute thyroiditis after infection with the SARS-CoV-2 ...

ea0081p449 | Reproductive and Developmental Endocrinology | ECE2022

Global impact of PCOS awareness month: challenges and opportunities

Malhotra Kashish , Synn Cuen Pan Carina , Davitadze Meri , Manolopoulos Konstantinos , O'Reilly Michael , Arlt Wiebke , Kempegowda Punith

Background: September is celebrated as PCOS awareness month worldwide and is aimed at improving the lives of those with PCOS, promoting research, and strengthening advocacy efforts. While significant financial and human resources are invested in promotions during this month, to the best of our knowledge, there is no evidence to show the impact of this initiative. In our study, we evaluated the global digital impact of PCOS Awareness Month, tracking commonly used hashtags as su...

ea0081ep751 | Pituitary and Neuroendocrinology | ECE2022

Immunohistochemichal expression of ephrin receptor (EPH)-A4, -A5, -B2 and -B5 in pituitary lesions

Papadimitriou Eirini , Kyriakopoulos Georgios , Barkas Konstantinos , Gkalonakis Ioannis , Pantoula Panagiota , Theocharis Stamatios , Kaltsas Gregory , Alexandraki Krystallenia

Introduction: Ephrin receptors (EPHs) compose the largest known subfamily of receptors tyrosine kinases and are bound and interact with EPHs-interacting proteins (Ephrins). They have a role in tumor growth, invasion, angiogenesis and metastasis of several neoplasms. Aim of the study was to investigate the expression of EPH-A4, -A5, -B2 and -B5 in pituitary lesions. Material and Methods: Our study group consisted of 18 patients (9 males with median age 54...

ea0089c4 | Clinical – Chemo/SSA/Biologics | NANETS2022

Cisplatin vs Carboplatin in Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas (PD NEC)

McLaughlin Nicole , McGarrah Patrick , Eiring Rachel , Leventakos Konstantinos , Sonbol Mohamad , Starr Jason , Hobday Timothy , Halfdanarson Thorvardur

Background: Extrapulmonary PD NECs carry a poor prognosis. Some studies suggest cisplatin is more appropriate for younger patients due to its increased potency and nephrotoxicity compared to carboplatin, but randomized trials are lacking. We aim to determine whether there is a difference in outcomes for cisplatin vs carboplatin while adjusting for possible confounding factors.Methods: We identified PD NEC patients at Mayo Clinic between 2000-2022. Kaplan...